{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:02:24Z","timestamp":1781013744620,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05622-3","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:47:10Z","timestamp":1780156030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9302-587X","authenticated-orcid":false,"given":"Dandan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1668-0774","authenticated-orcid":false,"given":"Xiaohao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9784-9522","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6654-7348","authenticated-orcid":false,"given":"Yubing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"5622_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE (2012) Diffuse intrinsic pontine glioma: poised for progress [J]. Front Oncol 2:205. https:\/\/doi.org\/10.3389\/fonc.2012.00205","journal-title":"Front Oncol"},{"issue":"3","key":"5622_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials [J]. Lancet Oncol 7(3):241\u2013248. https:\/\/doi.org\/10.1016\/S1470-2045(06)70615-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"5622_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","volume":"38","author":"M Jansen","year":"2012","unstructured":"Jansen M, Van Vuurden D, Vandertop W et al (2012) Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology [J]. Cancer Treat Rev 38(1):27\u201335. https:\/\/doi.org\/10.1016\/j.ctrv.2011.06.007","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"5622_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s003810050542","volume":"15","author":"CR Freeman","year":"1999","unstructured":"Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas [J]. Child\u2019s Nerv Syst 15(10):545\u2013553. https:\/\/doi.org\/10.1007\/s003810050542","journal-title":"Child\u2019s Nerv Syst"},{"issue":"5","key":"5622_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","volume":"43","author":"LR Mandell","year":"1999","unstructured":"Mandell LR, Kadota R, Freeman C et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy [J]. Int J Radiation Oncology* Biology* Phys 43(5):959\u2013964. https:\/\/doi.org\/10.1016\/S0360-3016(98)00501-X","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"2","key":"5622_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijrobp.2012.04.006","volume":"85","author":"GO Janssens","year":"2013","unstructured":"Janssens GO, Jansen MH, Lauwers SJ et al (2013) Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis [J]. Int J Radiation Oncology* Biology* Phys 85(2):315\u2013320. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.006","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"3","key":"5622_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"D-A Khuong-Quang","year":"2012","unstructured":"Khuong-Quang D-A, Buczkowicz P, Rakopoulos P et al (2012) K27M mutation in histone H3. 3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas [J]. Acta Neuropathol 124(3):439\u2013447. https:\/\/doi.org\/10.1007\/s00401-012-0998-0","journal-title":"Acta Neuropathol"},{"issue":"6134","key":"5622_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma [J]. Science 340(6134):857\u2013861. https:\/\/doi.org\/10.1126\/science.1232245","journal-title":"Science"},{"issue":"5","key":"5622_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S, Tang Y, Lindroth AM et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas [J]. Cancer Cell 24(5):660\u2013672. https:\/\/doi.org\/10.1016\/j.ccr.2013.10.006","journal-title":"Cancer Cell"},{"key":"5622_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary [J]"},{"key":"5622_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2844","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M et al (2022) JAMA Oncol 8(10):1493\u20131501. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2844. World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review [J]"},{"issue":"1","key":"5622_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0305-7372(97)90019-0","volume":"23","author":"ES Newlands","year":"1997","unstructured":"Newlands ES, Stevens MFG, Wedge SR et al (1997) Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials [J]. Cancer Treat Rev 23(1):35\u201361. https:\/\/doi.org\/10.1016\/s0305-7372(97)90019-0","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"5622_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van Den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J]. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"4","key":"5622_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/pbc.24060","volume":"58","author":"J Grill","year":"2012","unstructured":"Grill J, Puget S, Andreiuolo F et al (2012) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma [J]. Pediatr Blood Cancer 58(4):489\u2013491. https:\/\/doi.org\/10.1002\/pbc.24060","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"5622_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Pollack IF, Zhou T et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children\u2019s Oncology Group [J]. Neurooncology 13(3):317\u2013323. https:\/\/doi.org\/10.1093\/neuonc\/noq191","journal-title":"Neurooncology"},{"key":"5622_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","volume":"73","author":"GO Janssens","year":"2017","unstructured":"Janssens GO, Gandola L, Bolle S et al (2017) Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group [J]. Eur J Cancer 73:38\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.007","journal-title":"Eur J Cancer"},{"key":"5622_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23584","author":"A Broniscer","year":"2008","unstructured":"Broniscer A, Laningham FH, Sanders RP et al (2008) Cancer: Interdisciplinary Int J Am Cancer Soc 113(3):566\u2013572. https:\/\/doi.org\/10.1002\/cncr.23584. Young age may predict a better outcome for children with diffuse pontine glioma [J]"},{"issue":"2","key":"5622_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P et al (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma [J]. J Neurooncol 106(2):399\u2013407. https:\/\/doi.org\/10.1007\/s11060-011-0681-7","journal-title":"J Neurooncol"},{"issue":"4","key":"5622_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00381-012-1986-3","volume":"29","author":"R Kebudi","year":"2013","unstructured":"Kebudi R, Cakir FB, Agaoglu FY et al (2013) Pediatric diffuse intrinsic pontine glioma patients from a single center [J]. Child\u2019s Nerv Syst 29(4):583\u2013588. https:\/\/doi.org\/10.1007\/s00381-012-1986-3","journal-title":"Child\u2019s Nerv Syst"},{"issue":"5","key":"5622_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma [J]. Nat Genet 46(5):462\u2013466. https:\/\/doi.org\/10.1038\/ng.2950","journal-title":"Nat Genet"},{"key":"5622_CR21","doi-asserted-by":"publisher","unstructured":"Cronin KA, Scott S, Firth AU et al (2022) Annual report to the nation on the status of cancer, part 1: National cancer statistics [J]. Cancer, 128(24): 4251-84. https:\/\/doi.org\/10.1002\/cncr.34479","DOI":"10.1002\/cncr.34479"},{"issue":"33","key":"5622_CR22","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY, Van Den Bent M, Youssef G et al (2023) RANO 2.0: update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults [J]. J Clin Oncol 41(33):5187\u20135199. https:\/\/doi.org\/10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"key":"5622_CR23","first-page":"785","volume":"784","author":"S Shah","year":"2022","unstructured":"Shah S (2022) Common terminology criteria for adverse events [J]. Natl Cancer Institute: USA 784:785","journal-title":"Natl Cancer Institute: USA"},{"issue":"1","key":"5622_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00381-019-04363-1","volume":"36","author":"JS Rechberger","year":"2020","unstructured":"Rechberger JS, Lu VM, Zhang L et al (2020) Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs [J]. Child\u2019s Nerv Syst 36(1):39\u201346. https:\/\/doi.org\/10.1007\/s00381-019-04363-1","journal-title":"Child\u2019s Nerv Syst"},{"issue":"8","key":"5622_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary [J]. Neurooncology 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neurooncology"},{"key":"5622_CR26","unstructured":"Board W, C O T (2022) E. Central nervous system tumours [M]. World Health Organization"},{"issue":"1","key":"5622_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-024-04589-3","volume":"167","author":"V Di Nunno","year":"2024","unstructured":"Di Nunno V, Lombardi G, Simonelli M et al (2024) The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study [J]. J Neurooncol 167(1):145\u2013154. https:\/\/doi.org\/10.1007\/s11060-024-04589-3","journal-title":"J Neurooncol"},{"issue":"12","key":"5622_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11910-023-01317-8","volume":"23","author":"C Cacciotti","year":"2023","unstructured":"Cacciotti C, Wright KD (2023) Advances in Treatment of Diffuse Midline Gliomas [J]. Curr Neurol Neurosci Rep 23(12):849\u2013856. https:\/\/doi.org\/10.1007\/s11910-023-01317-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"5622_CR29","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1016\/j.wneu.2021.01.024","volume":"148","author":"S Shi","year":"2021","unstructured":"Shi S, Lu S, Jing X et al (2021) The prognostic impact of radiotherapy in conjunction with temozolomide in diffuse intrinsic pontine glioma: a systematic review and meta-analysis [J]. World Neurosurg 148:e565\u2013e71. https:\/\/doi.org\/10.1016\/j.wneu.2021.01.024","journal-title":"World Neurosurg"},{"issue":"3","key":"5622_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/cancers17030439","volume":"17","author":"JS Rechberger","year":"2025","unstructured":"Rechberger JS, Toll SA, Biswas S et al (2025) Advances in the Repurposing and Blood\u2013Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors [J]. Cancers 17(3):439. https:\/\/doi.org\/10.3390\/cancers17030439","journal-title":"Cancers"},{"key":"5622_CR31","doi-asserted-by":"publisher","unstructured":"Ringrose N, Atmaca S, Keil VC et al (2025) Dynamic contrast-enhanced magnetic resonance imaging in paediatric brain tumours systematically reviewed [J]. https:\/\/doi.org\/10.1007\/s00247-026-06600-7","DOI":"10.1007\/s00247-026-06600-7"},{"issue":"7384","key":"5622_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu X-Y et al (2012) Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma [J]. Nature 482(7384):226\u2013231. https:\/\/doi.org\/10.1038\/nature10833","journal-title":"Nature"},{"key":"5622_CR33","unstructured":"Karsonovich T, Hall W (2025) Diffuse Intrinsic Pontine Glioma [J]. StatPearls"},{"issue":"12","key":"5622_CR34","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma [J]. Nat Med 20(12):1394\u20131396. https:\/\/doi.org\/10.1038\/nm.3716","journal-title":"Nat Med"},{"issue":"1","key":"5622_CR35","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41467-019-09140-x","volume":"10","author":"AS Harutyunyan","year":"2019","unstructured":"Harutyunyan AS, Krug B, Chen H et al (2019) H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2\/me3 and is essential for glioma tumorigenesis [J]. Nat Commun 10(1):1262. https:\/\/doi.org\/10.1038\/s41467-019-09140-x","journal-title":"Nat Commun"},{"key":"5622_CR36","doi-asserted-by":"publisher","unstructured":"Lin GL, Monje M (2017) A protocol for rapid post-mortem cell culture of diffuse intrinsic pontine glioma (DIPG) [J]. J visualized experiments: JoVE 12155360. https:\/\/doi.org\/10.3791\/55360","DOI":"10.3791\/55360"},{"issue":"6","key":"5622_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma [J]. Nat Med 21(6):555\u2013559. https:\/\/doi.org\/10.1038\/nm.3855","journal-title":"Nat Med"},{"issue":"5","key":"5622_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","volume":"32","author":"M Pathania","year":"2017","unstructured":"Pathania M, De Jay N, Maestro N et al (2017) H3.3K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [J]. Cancer Cell 32(5):684\u2013700. https:\/\/doi.org\/10.1016\/j.ccell.2017.09.014","journal-title":"Cancer Cell"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05622-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:40:33Z","timestamp":1781012433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5622"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05622-3","relation":{"references":[{"id-type":"doi","id":"10.1007\/s00401-016-1545-1","asserted-by":"subject"},{"id-type":"doi","id":"10.1001\/jamaoncol.2022.2844","asserted-by":"subject"},{"id-type":"doi","id":"10.1002\/cncr.23584","asserted-by":"subject"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article has been revised: The affiliations of the 1st, 2nd, 3rd, 4th, 7th, 8th and 10th authors have been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (project number: TA2022-145 and ethics approval number: L\/G2022-K001-003). This study was performed according to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the parents or legal guardians of all pediatric patients (<\u200918 years of age) prior to study enrollment. For patients aged 7 years or older, verbal assent was also obtained from the child. For telephone follow ups, verbal informed consent was obtained from the guardians before each contact.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}